title: Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone.
authors.affiliation: Department of Hematology, S Eugenio Hospital, Tor Vergata University, Piazzale dell'Umanesimo 10, 00100 Rome, Italy. agostina.siniscalchi@gmail.com
authors.forename: A
authors.initials: A
authors.lastname: Siniscalchi
authors.forename: A
authors.initials: A
authors.lastname: Tendas
authors.forename: L
authors.initials: L
authors.lastname: Morino
authors.forename: T
authors.initials: T
authors.lastname: Dentamaro
authors.forename: A
authors.initials: A
authors.lastname: De Bellis
authors.forename: A
authors.initials: A
authors.lastname: Perrotti
authors.forename: P
authors.initials: P
authors.lastname: de Fabritiis
authors.forename: P
authors.initials: P
authors.lastname: Musto
authors.forename: T
authors.initials: T
authors.lastname: Caravita
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D000077269:Lenalidomide; D007952:Leukemia, Plasma Cell / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide